Fig. 5.

Myeloid (M) and CD3+ (C) cell chimerism of five patients with adverse outcomes related to donor cell infusions. Patient 2 had a second transplant which failed. Patient 7 had insufficient cells for analysis at day 30 and died prior to further analysis after day 100. Patient 21 had Evans syndrome with full myeloid chimerism at all points. Patient 24 received a donor cell infusion for persistent cytopenias in the context of ongoing infection but was fully engrafted in both compartments throughout. Patient 25 received a donor cell infusion after day 100 for cytopenias in the context of ongoing infection. Data sample numbers are consistent with patient designations in Table 1